Results 221 to 230 of about 2,117,768 (268)
Haemostatic changes during CART cell therapy and risk of complications. [PDF]
Cancer Immunol ImmunotherPanizo-Inogés M +12 more
europepmc +1 more source
Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations. [PDF]
Mol Ther OncolEscobar G, Maus MV.
europepmc +1 more source
Microfluidics for cell therapy and manufacturing in oncology and regenerative medicine.
Lab ChipDuncan JL, Arroyo JP, Davalos RV.
europepmc +1 more source
Revolution in Cell Therapy: In Vivo Chimeric-Antigen-Receptor-T-Cell Therapy Breakthroughs and Promises for the Future. [PDF]
Research (Wash D C)Lai M, Shao W, Mao J, Ye Q.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Veterinary Clinics of North America: Small Animal Practice, 2019
The necessity of improving the health and quality of life of subjects affected by diverse injuries and chronic diseases, has led to develop a new branch of translational medicine, called Regenerative Medicine (RegMed). RegMed has the principal objects of restoring, maintaining or enhancing structures and functions of tissues and organs.
De Falco E. +3 more
openaire +3 more sources
The necessity of improving the health and quality of life of subjects affected by diverse injuries and chronic diseases, has led to develop a new branch of translational medicine, called Regenerative Medicine (RegMed). RegMed has the principal objects of restoring, maintaining or enhancing structures and functions of tissues and organs.
De Falco E. +3 more
openaire +3 more sources